Possible mechanisms of A2AR antagonists on PD
What Gary Brecka Says About BPC-157 Gary Brecka, has explained the BPC-157 mechanism on the Joe Rogan podcast in some detail
Investigator-assessed improvement Finding: The blinded investigator assessed the active treatment group as showing Scale 1 improvement (2650% improvement) at the final visit, while the placebo group showed Scale 0 improvement (025%)
Its woven into every conversation
Endocrinology 119:14671475 rskov C, Jeppesen J, Madsbad S, Holst JJ (1991) Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
Supplements containing chromium, alpha-lipoic acid, or other compounds with glucose-lowering properties may have additive effects with tirzepatide